Quick Answer
AVANOS MEDICAL, INC. reported Research And Development Expense of $23.30 million for the year ending 2025.
- AVANOS MEDICAL, INC. showed a decrease of -11.1% in Research And Development Expense from 2024 to 2025.
- This data is from AVANOS MEDICAL, INC.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: $8.90 million | Q1 2014: $8.30 million | Q2 2014: $9.30 million | Q3 2014: $8.50 million | Q1 2015: $6.00 million | Q2 2015: $6.30 million | Q3 2015: $10.20 million | Q1 2016: $8.70 million | Q2 2016: $9.50 million | Q3 2016: $10.90 million | Q1 2017: $7.30 million | Q2 2017: $9.20 million | Q3 2017: $9.60 million | Q1 2018: $9.90 million | Q2 2018: $10.80 million | Q3 2018: $10.50 million | Q1 2019: $10.20 million | Q2 2019: $9.50 million | Q3 2019: $9.60 million | Q1 2020: $9.40 million | Q2 2020: $7.70 million | Q3 2020: $8.20 million | Q1 2021: $8.30 million | Q2 2021: $8.00 million | Q3 2021: $8.40 million | Q1 2022: $7.80 million | Q2 2022: $7.60 million | Q3 2022: $7.10 million | Q1 2023: $7.50 million | Q2 2023: $6.80 million | Q3 2023: $6.10 million | Q1 2024: $7.00 million | Q2 2024: $6.30 million | Q3 2024: $7.20 million | Q1 2025: $5.40 million | Q2 2025: $5.80 million | Q3 2025: $6.00 million.
- Over the full 14 years of available data (2012 to 2025), AVANOS MEDICAL, INC.'s Research And Development Expense has declined by 29.4%.
- Historical annual values: Fiscal year 2025: $23.30 million | Fiscal year 2024: $26.20 million | Fiscal year 2023: $27.20 million | Fiscal year 2022: $29.20 million | Fiscal year 2021: $30.60 million | Fiscal year 2020: $34.90 million | Fiscal year 2019: $37.70 million | Fiscal year 2018: $41.80 million | Fiscal year 2017: $38.20 million | Fiscal year 2016: $38.40 million | Fiscal year 2015: $27.60 million | Fiscal year 2014: $33.60 million | Fiscal year 2013: $37.90 million | Fiscal year 2012: $33.00 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: